The Supreme Prosecutors’ Office Special Investigation Division (SID) yesterday closed its investigation into Yu Chang Biologics Co (宇昌生技股份有限公司), now known as TaiMed Biologics Inc (中裕新藥股份有限公司), clearing former Democratic Progressive Party (DPP) chairperson Tsai Ing-wen (蔡英文) of any wrongdoing.
The SID launched its investigation during the presidential campaign after Chinese Nationalist Party (KMT) lawmakers accused Tsai of manipulating investments by the National Development Fund (NDF) in TaiMed when she was vice premier in 2007. Tsai served as chairperson of the biotech company for several months after she stepped down as vice premier in May 2007.
The SID said Tsai did not embezzle any money in the case or abuse any funds. All the money in the National Development Fund’s investment in TaiMed was legal and clear, it said.
The SID investigated Taiwan Biopharmaceuticals Co (南華生技), which applied for National Development Fund support in 2005 and 2007, and TaiMed Biotech Fund, which applied for funding in 2007 and 2008.
Taiwan Biopharmaceuticals was to be a pharmaceutical company founded in Taiwan by Nancy Chang (唐南珊), chairperson of Tanox — a US-based biopharmaceutical company — and then-Euroc Venture Capital Co chairman Kao Yu-jen (高育仁) for the research and development of a drug known as TNX-355.
TNX-355 is an anti-AIDS drug that may prevent HIV from breaching the immune system.
The SID investigation clarified why the National Development Fund refused Taiwan Biopharmaceuticals’ TNX-355 funding request, but provided funding to Yu Chang, which was importing and developing a similar drug from the US drug giant Genentech and later acquired Tanox in 2007.
The SID said there was no evidence that the National Development Fund’s decision resulted from external factors and there was no evidence that senior government officials lobbied for TaiMed.
Documents showed the fund’s decision not to provide support to Taiwan Biopharmaceuticals Co was because Tanox had been acquired by Genentech, and Taiwan Biopharmaceuticals Co did not clearly explain its future technology sources and the company’s development structure to the fund, the SID said.
The SID said that although both TaiMed and Taiwan Biopharmaceuticals Co planned to build plants and manufacture products in Taiwan, Taiwan Biopharmaceuticals Co’s plan was to manufacture 80 percent of Tanox’s orders, but TaiMed’s proposal was that TaiMed and Genentech cooperate to develop TNX-355 and that the new drug, if developed successfully, would be manufactured in Taiwan.
The SID said the Tsai family invested in TaiMed using their own money and that all the funding was clean.
The SID said it interviewed more than 30 people during the investigation, including former premier Su Tseng-chang (蘇貞昌), former Council for Economic Planning and Development (CEPD) chairpersons Ho Mei-yueh (何美玥) and Hu Sheng-cheng (胡勝正), and Yu Chang funders David Ho (何大一), an AIDS expert, and Chen Lan-bo (陳良博), a Harvard University professor.
The SID said Hu, who may have violated laws regarding the private-public boundary, was sent to the Taipei District Prosecutors’ Office for investigation.
Hu served as chairperson of TaiMed after leaving his post at the council.
The SID also sent former National Development Fund deputy executive director James Ho (何俊輝) to the Control Yuan for investigation because it said he had inappropriately discussed Yu Chang’s proposal at Tsai’s residence and office.
In a press release, Tsai said she has always been honest about her role and involvement in Yu Chang Biologics, which she said was a collaboration between the administrative and legislative branch to promote development of Taiwan’s biotechnology industry.
However, she said the KMT administration used the case as a political tool during the presidential campaign, a move that not only tainted the reputation of several renowned scientists, but also hurt the development of the sector.
“While the [SID’s] decision has proven the innocence of the people involved, it would be very difficult for me to say that I’m happy with the results,” Tsai said.
Tsai said she was not surprised by the findings, adding that she hoped the case would be an example for elections in the future.
“We hope the mud-slinging tactics will stop right here and the national leader will no longer employ government agencies for political gain,” Tsai said.
Additional reporting by staff reporter Chris Wang
A TAIWAN FIRST: The duo are the first badminton players from Taiwan to climb an Olympic podium, and Tai Tzu-ying has a shot at doing the same today Taiwanese badminton duo Lee Yang (李洋) and Wang Chi-lin (王齊麟) yesterday won the nation’s first Olympic gold medal in the sport when they prevailed over a third-seeded Chinese pair in the final of the men’s doubles at the Tokyo Olympics. Lee and Wang, both first-time Olympians, defeated Liu Yuchen (劉雨辰) and Li Junhui (李俊慧) 21-18, 21-12 in a 34-minute final at the Musashino Forest Sports Plaza. As of yesterday, Taiwan had bagged seven medals in Tokyo — two golds, two silvers and three bronzes — topping its previous best of five medals in 2000 and 2004. Taiwan moved to No. 17 in the
NO ‘ONE CHINA’ LIE: The appropriations act passed the US House of Representatives with a vote of 217-212, but still needs Senate approval and the president’s signature The US House of Representatives on Wednesday passed a foreign assistance spending bill with an amendment forbidding that funds be used to create, procure or display maps depicting Taiwan as part of the People’s Republic of China. The amendment was introduced by five Republican representatives — Tom Tiffany, Steve Chabot, Scott Perry, Kat Cammack and Mike Gallagher — and passed unanimously in a bundle with a dozen other amendments. “This is a common sense measure,” Tiffany said, speaking on the House floor on Wednesday. “As we all know, Taiwan has never been part of communist China. The Taiwanese people elect their
‘TEAM TAIWAN’: Taiwanese athletes have performed admirably and raised the nation’s profile, but many abroad still think they are Chinese, an advocate said Advocacy groups have called for the national team to compete under the name “Taiwan” at the Tokyo Olympics, while former Olympian Chi Cheng (紀政) has launched another referendum petition on the issue. Taiwanese athletes have performed outstandingly at the Olympics and have raised the nation’s profile on the world stage, Northern Taiwan Society chairman Lee Chuan-hsin (李川信) said on Friday. “Many foreign news agencies, including Japan’s NHK, have called our delegation ‘Taiwan’ instead of ‘Chinese Taipei.’ Therefore our own people and politicians should also speak of ‘Team Taiwan’ and Taiwanese athletes,” he said. “However, in Taiwan, most of the time the Taiwanese team
THE HOME TEAM: DPP Legislator Kao Chia-yu said she canceled her booking for an AstraZeneca shot as soon as she heard that the Medigen vaccine was an option President Tsai Ing-wen (蔡英文) yesterday said that she would get inoculated with the COVID-19 vaccine manufactured by Taiwan-based Medigen Vaccine Biologics Corp (高端疫苗). Tsai wrote on Facebook that she had registered for her first vaccine dose using the national online COVID-19 vaccination booking system, which allows people to indicate their preferred vaccine brand and to make an appointment when the shot becomes available. Tsai said that she opted for the Medigen vaccine — one of three now available on the system, along with the AstraZeneca and Moderna vaccines — even though Medigen has yet to deliver any doses or provide a